Award-winning researcher explains how his work seeks to better understand osteosarcoma’s genomic instability to uncover novel treatments for the most aggressive types of the disease.
Stories of Progress, Inspiration & Support
Research & Breakthroughs
Innovation and studies to improve patient outcomes
Osteosarcoma researcher Jason T. Yustein, MD, PhD, seeks to better understand the disease by testing various combinations of drugs to treat it.
We sat down with Ryan Roberts, MD, PhD, to find out how cancer cells are different from normal cells and what he thinks are the most promising areas in osteosarcoma research.
Bringing together clinical, genomic, and imaging data in a user-friendly format, the Osteosarcoma Explorer is designed to accelerate osteosarcoma research and encourage new contributions to the field.
Leading osteosarcoma researchers explain why it has been difficult to develop immunotherapy drugs to treat pediatric bone cancer and discuss promising signs for the future.
This year, the Osteosarcoma Institute awarded over $1.7 million across four innovative osteosarcoma research projects.
No results found.
Sign Up to Receive The Frontline
at vero eos et accusamus et iusto odio dignis simos duccimus qui blanditis
We never sell or share your information.
Your donation provides immediate and long-term support to osteosarcoma patients.